{"id":"https://openalex.org/W3027414801","doi":null,"title":"Eficacia de los antagonistas de la serotonina en las n\u00e1useas y v\u00f3mitos no relacionados con quimioterapia antineopl\u00e1sica y resistentes al tratamiento habitual","display_name":"Eficacia de los antagonistas de la serotonina en las n\u00e1useas y v\u00f3mitos no relacionados con quimioterapia antineopl\u00e1sica y resistentes al tratamiento habitual","publication_year":2000,"publication_date":"2000-01-01","ids":{"openalex":"https://openalex.org/W3027414801","mag":"3027414801"},"language":"es","primary_location":{"id":"mag:3027414801","doi":null,"is_oa":false,"landing_page_url":"https://dialnet.unirioja.es/servlet/articulo?codigo=7388669","pdf_url":null,"source":{"id":"https://openalex.org/S121682720","display_name":"Medicina Paliativa","issn_l":"1134-248X","issn":["1134-248X","2340-3292"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Medicina Paliativa","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068377444","display_name":"Albert Tuca","orcid":"https://orcid.org/0000-0002-4633-5856","observed_orcids":["https://orcid.org/0000-0002-4633-5856"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Albert Tuca","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4633-5856","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111063001","display_name":"J. Porta Sales","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Porta Sales","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034137033","display_name":"Jos\u00e9 Manuel Porcel P\u00e9rez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jos\u00e9 Manuel Porcel P\u00e9rez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084613054","display_name":"Elfrida Diana Salut","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Salut","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066638693","display_name":"Carme Sala","orcid":"https://orcid.org/0000-0001-7004-4867","observed_orcids":["https://orcid.org/0000-0001-7004-4867"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carme Sala","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7004-4867","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015517615","display_name":"Jordi Trelis Navarro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jordi Trelis Navarro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5016077090","display_name":"Xavier G\u00f3mez Batiste","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xavier G\u00f3mez Batiste","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"7","issue":"2","first_page":"62","last_page":"66"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11785","display_name":"Nausea and vomiting management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11785","display_name":"Nausea and vomiting management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13340","display_name":"Palliative and Oncologic Care","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/serotonergic-antagonists","display_name":"serotonergic antagonists","score":0.6600000262260437},{"id":"https://openalex.org/keywords/ondansetron","display_name":"ondansetron","score":0.9900000095367432},{"id":"https://openalex.org/keywords/granisetron","display_name":"granisetron","score":1.0},{"id":"https://openalex.org/keywords/chemotherapy-induced-nausea-and-vomiting","display_name":"chemotherapy-induced nausea and vomiting","score":0.9459999799728394},{"id":"https://openalex.org/keywords/refractory-nausea-and-vomiting","display_name":"refractory nausea and vomiting","score":0.859000027179718},{"id":"https://openalex.org/keywords/palliative-care","display_name":"palliative care","score":0.7179999947547913},{"id":"https://openalex.org/keywords/cancer-patients","display_name":"cancer patients","score":0.7269999980926514},{"id":"https://openalex.org/keywords/subcutaneous-administration","display_name":"subcutaneous administration","score":0.8550000190734863},{"id":"https://openalex.org/keywords/antiemetic-efficacy","display_name":"antiemetic efficacy","score":0.9279999732971191},{"id":"https://openalex.org/keywords/drug-tolerance","display_name":"drug tolerance","score":0.656000018119812},{"id":"https://openalex.org/keywords/continuous-infusion","display_name":"continuous infusion","score":0.6100000143051147},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.4909999966621399},{"id":"https://openalex.org/keywords/drug-bioavailability","display_name":"drug bioavailability","score":0.4020000100135803},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.5059999823570251}],"concepts":[{"id":"https://openalex.org/C2777170512","wikidata":"https://www.wikidata.org/wiki/Q410011","display_name":"Ondansetron","level":3,"score":0.4637252688407898},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39002740383148193},{"id":"https://openalex.org/C15708023","wikidata":"https://www.wikidata.org/wiki/Q80083","display_name":"Humanities","level":1,"score":0.3837777376174927},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.3597054183483124},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.21077263355255127},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.09485292434692383},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.07629305124282837}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3027414801","doi":null,"is_oa":false,"landing_page_url":"https://dialnet.unirioja.es/servlet/articulo?codigo=7388669","pdf_url":null,"source":{"id":"https://openalex.org/S121682720","display_name":"Medicina Paliativa","issn_l":"1134-248X","issn":["1134-248X","2340-3292"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Medicina Paliativa","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2049279956","https://openalex.org/W2401292389","https://openalex.org/W1984463305","https://openalex.org/W124840879","https://openalex.org/W2058734928","https://openalex.org/W1995925329","https://openalex.org/W7007515721","https://openalex.org/W2052109081","https://openalex.org/W2319719212","https://openalex.org/W2281421655"],"abstract_inverted_index":{"espanolObjetivo:":[0],"La":[1,183,245],"incidencia":[2],"de":[3,13,30,39,42,51,63,68,82,93,101,126,141,154,180,189,227,236,249,275,277,282],"nauseas":[4,83,94,238],"y":[5,66,72,84,114,132,148,165,175,209,239,247],"vomitos":[6,75,85,105,240],"en":[7,26,47,74,158,168,172,177,233,285],"cuidados":[8],"paliativos":[9],"supera":[10],"el":[11,17,48,124,159,178,234,280],"40%":[12],"los":[14,31,40,52,181,225],"enfermos.":[15,182],"Con":[16],"tratamiento":[18,56,78,110,187,243],"antiemetico":[19,50,111,196],"habitual":[20,113],"se":[21,203],"consigue":[22],"un":[23,194],"control":[24,49,195,235,308,318,452],"adecuado":[25,197],"mas":[27,104],"del":[28,70,186],"90%":[29,312],"casos.":[32],"Este":[33],"estudio":[34,122],"pretende":[35],"determinar":[36,276],"la":[37,43,64,99,127,210,213,228,250,261,286],"eficacia":[38,69,131,246],"antagonistas":[41,226],"serotonina":[44,229],"(ondansetron,":[45],"granisetron)":[46],"enfermos":[53,139,199],"refractarios":[54],"al":[55,77,109,115,242],"habitual.":[57,79,244],"Metodo:":[58],"Estudio":[59],"multicentrico":[60],"retrospectivo.":[61],"Valoracion":[62],"utilizacion":[65],"tasa":[67],"ondansetron":[71,412],"granisetron":[73],"resistentes":[76,86,241],"El":[80],"criterio":[81],"fue":[87,188,216],"una":[88],"Escala":[89],"Visual":[90,359],"Analogica":[91],"(EVA)":[92],"superior":[95],"a":[96,212,358,511],"4":[97,365],"y/o":[98],"presencia":[100],"2":[102,369],"o":[103],"diarios,":[106],"sin":[107],"respuesta":[108],"considerado":[112],"mejor":[116],"soporte":[117],"posible":[118],"no":[119,288],"farmacologico.":[120],"Se":[121,135,192],"tambien":[123],"uso":[125],"via":[128,265],"subcutanea,":[129],"su":[130],"tolerancia.":[133],"Resultados:":[134],"han":[136],"estudiado":[137],"31":[138,403],"oncologicos,":[140],"estos":[142,283],"25":[143,408],"fueron":[144,156,253],"tratados":[145],"con":[146,150],"Ondansetron":[147],"6":[149,414],"Granisetron.":[151],"Las":[152],"vias":[153],"administracion":[155,214,251],"subcutanea":[157,215,252],"68":[160],"%":[161,163,167,174],"(58":[162],"discontinua":[164],"10":[166],"infusion":[169],"continua),":[170],"oral":[171,434],"22":[173],"endovenosa":[176],"10%":[179,429,436],"duracion":[184],"media":[185],"14":[190,446],"dias.":[191],"consiguio":[193],"26":[198,454],"(84":[200],"%).":[201],"No":[202],"observaron":[204],"efectos":[205],"secundarios":[206],"sistemicos":[207],"significativos":[208],"tolerancia":[211,248],"excelente.":[217],"Discusion:":[218],"Estos":[219],"datos":[220],"nos":[221,257],"permiten":[222],"concluir":[223],"que":[224,256,260],"son":[230],"farmacos":[231,284],"utiles":[232],"las":[237],"altas,":[254],"lo":[255],"hace":[258],"suponer":[259],"biodisponibilidad":[262],"por":[263,290],"esta":[264],"es":[266],"sufienciente.":[267],"Seria":[268],"interesante":[269],"plantear":[270],"ensayos":[271],"clinicos":[272],"controlados":[273],"capaces":[274],"forma":[278],"definitiva":[279],"papel":[281],"emesis":[287],"inducida":[289],"quimioterapia":[291],"EnglishObjective:":[292],"The":[293,320,352,417,440],"incidence":[294],"of":[295,313,323,331,354,368,375,392,424,443,513,522],"vomiting":[296,307,335,356,487,526],"in":[297,309,334,422,453,525],"Palliative":[298],"Care":[299],"is":[300,326,507,510],"estimated":[301],"over":[302],"40%.":[303],"We":[304,387,457],"can":[305],"achieve":[306],"more":[310,367],"than":[311,364],"cases":[314],"with":[315,411,415],"standard":[316,345,378,490],"symptom":[317],"protocols.":[319],"main":[321],"objective":[322],"this":[324,505],"study":[325],"to":[327,338,343,377,466,475,489,517,529],"determine":[328],"the":[329,382,390,464,478,486,520],"efficacy":[330,399],"serotonin":[332,479],"antagonist":[333],"not":[336,527],"due":[337,528],"cancer":[339,404,530],"chemotherapy":[340,531],"and,":[341],"non-responsive":[342,355,488],"antiemetic":[344,379,451],"treatment.":[346,491],"Method:":[347],"Multicenter":[348],"and":[349,373,381,395,400,413,428,435,463,497],"retrospective":[350],"study.":[351],"criteria":[353],"was":[357,420,433,437,445,469,494],"Analogic":[360],"Schedule":[361],"(VAS)":[362],"higher":[363],"and/or":[366],"vomits":[370],"per":[371],"day,":[372],"lack":[374],"response":[376],"treatment":[380,444],"best":[383],"possible":[384],"non-pharmacological":[385],"support.":[386],"also":[388],"recorded":[389],"use":[391],"subcutaneous":[393,421,467],"route":[394,419,493],"we":[396,449],"studied":[397],"its":[398],"tolerance.":[401],"Results:":[402],"patients":[405,425,455],"were":[406,409],"studied,":[407],"treated":[410],"granisetron.":[416],"administration":[418],"68%":[423],"(58%":[426],"intermittent":[427],"continuous":[430],"infusion),":[431],"22%":[432],"intravenous":[438],"route.":[439],"mean":[441],"duration":[442],"days.":[447],"Globally":[448],"achieved":[450],"(84%).":[456],"didn\u2019t":[458],"observe":[459],"systemic":[460],"side":[461],"effects":[462],"tolerance":[465],"injection":[468],"excellent.":[470],"Discussion:":[471],"These":[472],"findings":[473],"permit":[474],"conclude":[476],"that":[477,504],"antagonists":[480],"are":[481],"useful":[482],"drugs":[483,524],"for":[484],"treat":[485],"Subcutaneous":[492],"highly":[495],"effective":[496],"well":[498],"tolerated,":[499],"which":[500],"makes":[501],"us":[502],"think":[503],"bioavailability":[506],"enough.":[508],"There":[509],"need":[512],"controlled":[514],"clinical":[515],"trials":[516],"clarify":[518],"definitively":[519],"usefulness":[521],"these":[523]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2020-05-29T00:00:00"}